Assessment: positron emission tomography. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
D001932:Brain Neoplasms / Q000000981:diagnostic imaging; D003072:Cognition Disorders / Q000000981:diagnostic imaging; D003704:Dementia / Q000000981:diagnostic imaging; D003847:Deoxyglucose / Q000031:analogs & derivatives; D003937:Diagnosis, Differential; D005069:Evaluation Studies as Topic; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D005544:Forecasting; D006801:Humans; D010104:Oxygen Radioisotopes; D011300:Preoperative Care; D012640:Seizures / Q000601:surgery; D014055:Tomography, Emission-Computed / Q000009:adverse effects / Q000379:methods / Q000592:standards*
D005462:Fluorine Radioisotopes; D010104:Oxygen Radioisotopes; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose